News
One mum with first-hand experience of managing her child's allergies is offering her wisdom to others facing similar ...
ALK (ALKB.DC / OMX: ALK B) today announced that its European regulatory filing for ITULAZAX® (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents aged ...
ALK (ALKB.DC / OMX: ALK B) today announced that its European regulatory filing for ITULAZAX® (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents aged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback